The prescription of nutritional supplements is one of the most common treatments for autism but little research exists about the effectiveness of supplements in autistic children and adults. According to the authors of this study, 49% of physicians recommend vitamin / mineral supplements for children with autism. In light of this fact, the authors designed a trial to determine if the recommendation is useful. The randomized, double-blind, placebo-controlled three month vitamin / mineral intervention study was published in December 2011. The study involved 141 children and adults with autism. The researchers insured that none of the participants had taken a vitamin / mineral supplement for at least 2 months prior to the commencement of the study. The outcomes that were assessed during the trial included nutritional status, metabolic status and scores on the Parental Global Impressions – Revised (PGI-R) Scale. The PGI-R is an assessment tool that asks caregivers to rate the changes in certain symptoms over time on a scale from 1 to 7 with 1 being ‘much worse’ and 7 being ‘much better.’ The symptoms specified by the PGI-R are Expressive Language, Receptive Language, Hyperactivity, Tantrumming, Play, Cognition, Gastrointestinal Symptoms, Sleep, Sociability, Eye Contact, and Overall.
When compared with healthy children, children with autism had statistically significant differences in their average levels of many important molecules such as biotin, glutathione, S-adenosylmethionine (SAM), plasma ATP and plasma tryptophan. The autistic children also had higher levels of oxidative stress biomarkers. During the study, the participants had a compliance rate of over 95% and both the vitamin / mineral supplement and the placebo were well tolerated. The participants in the supplement group improved the levels of all of the biomarkers and in some cases, completely normalized the levels to match those of healthy children. I should probably mention that lab tests were only performed with the local children who participated in the study. Therefore, most of the reported results are in reference to the small group of local pediatric participants (there were 53 children ages 5-16 in this group). All 141 participants were assessed using the PGI-R Scale at the conclusion of the study.
Overall, the participants in the supplement group had significantly greater improvement than the placebo group on the Average Change of the PGI-R scores. The supplement group actually reported approximately twice the improvement when compared with the placebo group. The Average Change of the PGI-R scores refers to the overall combined average of all the PGI-R scores. The most interesting part of this study is the association of certain nutrient levels with the Average Change of the PGI-R scores. Through statistical analysis, the researchers determined that the levels of biotin, Vitamin K and lipoic acid were strongly associated with the Average Change of the PGI-R scores in the small sub-group of local children. As pointed out by the authors of the study, both biotin and Vitamin K are produced in the intestines by the beneficial bacteria known as probiotics. It is estimated that half of the biotin and Vitamin K in humans is produced by our intestinal flora. It is also known that children with autism not only have a higher incidence of GI problems than healthy children but also, on average, have a much higher use of oral antibiotics in their past medical history than healthy children. After reading these results I performed a quick literature search to find out if anyone had supplemented autistic patients with probiotics and then measured the outcome. Shockingly, no trials have ever been performed looking at the potential benefits of probiotic supplementation in autistic patients (according to PubMed). Currently there is not even a trial in progress (I checked the NIH Registry) that is looking at probiotics as a potential treatment for the symptoms of autism. I did find several published reviews that suggest controlled intervention trials should be designed and performed but to date, none are being performed. It will be a long time before we know if probiotic supplementation in autistic patients is helpful but, for now, thanks to this study, we do know that prescribing a multi vitamin / mineral to autistic patients is a well-tolerated, reasonable and beneficial treatment.
Laura Firetag ND Student Bastyr University
Adams, James, Tapan Audhya, et al. "Effect of a Vitamin/mineral Supplement on Children and Adults with Autism." Biomed Central Pediatrics. 11.111 (2011). Web. 18 Jan. 2012.
Science has taught us that mushrooms can be far more than a tasty pizza topping or a meaty stir-fry ingredient. While it has long been known that mushrooms possess medicinal properties, current research has identified active chemical constituents and assessed their effectiveness in treating various medical conditions.
The reishi mushroom (Ganoderma lucidum) has been used in traditional Chinese medicine for thousands of years. Harvested from decaying logs and tree stumps in the coastal provinces of China, reishi, or ling zhi, is highly prized as an elixir of immortality. The royalty of ancient China used it in their quest for immortality and to promote calmness. Sixteenth century Chinese practitioners utilized it to affect the life energy (qi) of the heart, treat ailments of the chest, increase intellectual capacity, and improve memory.
Purported uses of reishi mushrooms include hypertension, high cholesterol, viral infections, liver disorders, and immune modulation. What is it about reishi mushrooms that makes them so useful medicinally? The answer lies in the mushroom’s active chemical constituents:
§Triterpenes. The triterpenes, which include ganodermic acids, are reported to have antihypertensive effects. Studies indicate that reishi’s triterpenes may reduce blood pressure in two ways: 1) by acting on the central nervous system, and 2) by inhibiting angiotensin converting enzyme (like a pharmaceutical ACE inhibitor) to promote vasodilation. Triterpenes are also thought to be responsible for lowering cholesterol levels by acting on 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA), the key enzyme involved in making cholesterol.
§Polysaccharides. Reishi’s polysaccharides, such as beta glucans, have been shown to stimulate the activity of immune cells (such as macrophages) and increase the levels of protective substances (such as TNF and interleukins) that they produce. Such actions make reishi an effective treatment for viral infections such as influenza, HIV, herpes simplex, and Epstein-Barr virus. In addition, in vitro studies have found that reishi’s polysaccharides inhibit tumor cell growth. Polysaccharides isolated from reishi are also attributed to improvements in liver function, as indicated by decreases in serum liver enzymes: aspartate transaminase (AST), alanine transaminase (ALT), and alkaline phosphatase. The studies also revealed decreased total bilirubin and liver collagen content.
§Adenosine. The high levels of adenosine in reishi are thought responsible for inhibiting platelet aggregation, which may make the mushroom a potential therapy for coronary heart disease treatment and prevention.
Reishi’s cancer-fighting capabilities continue to be a key area of scientific research. Small clinical studies using reishi reveal increased antioxidant activity and immune responses in patients with advanced disease. Furthermore, reishi shows great potential as a supportive treatment for patients undergoing chemotherapy: In vitro and animal studies indicate that reishi increases the sensitivity of cancer cells to chemotherapy, alleviates chemotherapy-induced nausea, and prevents chemotherapy-induced nephrotoxicity.
The benefits don’t stop there! Nutritionally, reishi mushrooms are great sources of selenium, iron, protein, and dietary fiber. Now that’s a mighty mushroom!
Karen Brothers, ND student, NCNM
To learn more about reishi mushrooms, check out these references:
§Gaby, Alan R. and Healthnotes, Inc. The Natural Pharmacy. New York: Three Rivers Press, 2006.
Schizophrenia is a rare disorder that strikes young adults who are about to enter the prime of their lives.The average onset occurs in the early to mid-20s for males and the late 20s for females.While it is rare, since it strikes at such a tender age, schizophrenia is actually one of the 10 leading causes of disability among people 15-44 years old.
In conventional (allopathic) medicine, the standard treatment of schizophrenia involves the use of anti-seizure and antipsychotic pharmaceuticals such as haloperidol, chlorpromazine, clozapine and fluphenazine.Benzodiazepines can also be used adjunctively during the acute phase of illness with some success.Overall, the treatment of schizophrenia using pharmaceutical interventions can cause significant side effects and provides heterogeneous outcomes.Anecdotally, it has been observed that approximately one-third of patients will have a relatively good outcome; one-third will have a poor outcome with significant psychosocial impairment and persistent psychotic symptoms while the remaining one-third will have an outcome somewhere in the middle of the two extremes.This observation is known as the ‘rule of thirds.’Fortunately, there is a promising naturopathic treatment that could lead to better patient outcomes.
Dr. Abram Hoffer has been studying the effects of supplemental niacin in schizophrenic patients for over 50 years.In 1952, Dr. Hoffer postulated the adrenochrome theory of schizophrenia.Adrenochrome is a derivative of oxidized adrenaline.A methyl group is required in order to produce adrenaline from noradrenaline.Vitamin B3 is a methyl acceptor which can reduce the methylation of noradrenaline to adrenalin and therefore decrease the production of adrenochrome.Vitamin B3 is also a precursor to NAD/NADH which can reverse the oxidation of adrenaline.By decreasing the oxidation of adrenaline, the production of neurotoxic adrenochrome also decreases.
To prove his hypothesis, Dr. Hoffer designed and commenced intervention trials.His first study, published in 1957, randomized 30 schizophrenic patients to niacin, niacinamide or placebo.The participants were given standard pharmacologic therapy plus 1 gram of the intervention three times a day for 30 days and then followed for a year.After one year, the participants supplemented with Vitamin B3 had an 80% recovery rate as compared to the placebo group which had a 33% recovery rate.‘Hoffer followed patients from 1953 to 1960, publishing a total of six double-blind, randomized controlled clinical trials. All trials confirmed the positive effects that vitamin B3 had on the recovery of acute schizophrenic patients, and that the use of this vitamin substantially reduced patients’ reliance on the health care system.(2)’In an ‘analysis of 27 chronic schizophrenic patients who had been under treatment for at least 10 years, consistent treatment with vitamin B3 produced the following results: 11 patients were able to work; two patients were able to marry and look after their families and homes; two patients were single mothers able to care for their children; and three patients were able to manage their own businesses.(2)’Based on this analysis, long-term niacin therapy has significantly better outcomes when compared to the ‘rule of thirds’ seen with purely pharmacologic interventions.Optimal doses of niacin also have less devastating side effects when compared to the pharmaceuticals typically prescribed to schizophrenic patients.
While this treatment has yet to be universally accepted by conventional medicine, a relevant study that involved collaboration between The University of Pittsburgh, thePortland VA Medical Center and the VA Pittsburgh Healthcare System was published in September of 2010.The study concluded thatthere is in fact a schizophrenia-associated niacin response abnormality and attempted to determine a potential cause for the reduced niacin skin flush.Hopefully over time, more studies that investigate the connection between niacin and schizophrenia will provide concrete answers and a treatment regimen that is accepted by conventional medicine.Until then, Dr. Abram Hoffer recommends that schizophrenic adults begin with one gram of niacin three times a day and slowly increase to 4,500-18,000 mg per day to achieve the best possible outcome.Dr. Hoffer also recommends other nutrients in addition to niacin such as Vitamin C.Please consult the references below, especially the Alternative Medicine Review, and your naturopathic physician before attempting to implement this nutrient protocol.
Laura Firetag ND Student Bastyr University
References:
1)Hoffer, A, and J Prousky. "Successful Treatment of Schizophrenia Requires Optimal Daily Doses of Vitamin B3." Alternative Medicine Review. 13.4 (2008): 287-91. http://www.altmedrev.com/publications/13/4/287.pdf
2)Andreasen, Nancy, and Donald Black. Introductory Textbook of Psychiatry. 4th. Washington, DC: American Psychiatric Publishing, Inc., 2006. Print.
Disclaimer: All data and information provided on this blog is for informational purposes only. Innate Response
Formulas makes no representations as to accuracy, completeness, suitability, or validity of any information on this blog and will not be liable for the content. All information is provided on an as-is basis.